Jesper Lind
Nessuna posizione attualmente
Storia della carriera di Jesper Lind
Precedenti posizioni note di Jesper Lind
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| OREXO AB | Direttore operativo | 01/11/2013 | 31/12/2018 |
| MOBERG PHARMA AB | Corporate Officer/Principal | 01/01/2022 | - |
| ALFA LAVAL AB | Corporate Officer/Principal | - | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - | - |
Formazione di Jesper Lind
| Royal Institute of Technology | Graduate Degree |
| The University of Sydney | Graduate Degree |
Statistiche
Distribuzione geografica
| Svezia | 6 |
| Australia | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Graduate Degree | 2 |
| Chief Operating Officer | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| OREXO AB | Health Technology |
| ALFA LAVAL AB | Producer Manufacturing |
| MOBERG PHARMA AB | Health Technology |
| Aziende private | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Borsa valori
- Insiders
- Jesper Lind
- Esperienza
